Tumor Physiology and Charge Dynamics of Anticancer Drugs: Implications for Camptothecin-based Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|9|1367-1372

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.9, 2011-03, pp. : 1367-1372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Camptothecin-based strategies for malignant disease

By  

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Promise and challenges in drug discovery and development of hybrid anticancer drugs

By Gediya Lalji K   Njar Vincent CO  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 11, 2009-11 ,pp. : 1099-1111

Informa Healthcare

Access to resources Recommend Favorite

Methods for Elucidation of DNA-Anticancer Drug Interactions and their Applications in the Development of New Drugs

By  

Current Pharmaceutical Design, Vol. 22, Iss. 44, 2017-01 ,pp. : 6596-6611

Bentham Science Publishers

Access to resources Recommend Favorite

The Metabolism of Anticancer Drugs by the Liver: Current Approaches to the Drug Development Process

By  

Current Drug Metabolism, Vol. 16, Iss. 7, 2015-09 ,pp. : 506-521

Bentham Science Publishers

Access to resources Recommend Favorite

An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 19, 2016-08 ,pp. : 2156-2168

Bentham Science Publishers

Access to resources Recommend Favorite